Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
CBRE Group
CBRE
$44B
| $13.2M | 0.02% |
349,188
-336,637
| -49% | -$12.4M |
|
|
LUMO
1052
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $13.2M | 0.02% |
144,290
+118,243
| +454% | +$9.07M |
|
|
OPB
1053
DELISTED
Opus Bank Common Stock
OPB
| $13.2M | 0.02% |
549,903
+408,927
| +290% | +$9.47M |
|
1054
Manitowoc
MTW
$710M
| $13.2M | 0.02% |
365,978
+248,300
| +211% | +$7.22M |
|
|
CXO
1055
CALL
DELISTED
CONCHO RESOURCES INC.
CXO
| $13.2M | 0.02% |
+100,000
| New | +$12M |
|
|
NAV
1056
DELISTED
Navistar International
NAV
| $13.1M | 0.02% |
298,372
+278,562
| +1,406% | +$9.24M |
|
|
BAS
1057
DELISTED
Basis Energy Services, Inc.
BAS
| $13.1M | 0.02% |
681,177
-780,088
| -53% | -$15.5M |
|
1058
3M
MMM
$92.3B
| $13.1M | 0.02% |
+74,842
| New | +$13M |
|
|
MITL
1059
DELISTED
Mitel Networks Corporation
MITL
| $13.1M | 0.02% |
1,564,969
+1,441,689
| +1,169% | +$11.5M |
|
1060
MidCap Financial Investment
MFIC
$801M
| $13.1M | 0.02% |
716,172
+83,915
| +13% | +$1.56M |
|
1061
CALL
Plains GP Holdings
PAGP
$5.4B
| $13.1M | 0.02% |
+600,000
| New | +$14.2M |
|
|
CRZO
1062
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $13.1M | 0.02% |
764,082
-508,509
| -40% | -$7.43M |
|
|
WBT
1063
DELISTED
Welbilt, Inc.
WBT
| $13.1M | 0.02% |
567,435
+191,038
| +51% | +$3.86M |
|
1064
SITE Centers
SITC
$161M
| $13.1M | 0.02% |
1,108,068
+927,071
| +512% | +$11.6M |
|
|
DCPH
1065
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $13.1M | 0.02% |
+688,231
| New | +$12.6M |
|
1066
Curtiss-Wright
CW
$22.7B
| $13.1M | 0.02% |
124,908
-149,878
| -55% | -$14.5M |
|
|
SP
1067
DELISTED
SP Plus Corporation
SP
| $13.1M | 0.02% |
330,543
+97,870
| +42% | +$3.44M |
|
1068
Preferred Bank
PFBC
$1.23B
| $13.1M | 0.02% |
216,307
+105,065
| +94% | +$5.79M |
|
|
NGD
1069
DELISTED
New Gold Inc
NGD
| $13M | 0.02% |
+3,514,379
| New | +$12.1M |
|
1070
Zillow
ZG
$8.53B
| $13M | 0.02% |
324,707
+264,893
| +443% | +$11.2M |
|
|
CBPX
1071
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $13M | 0.02% |
501,070
+87,612
| +21% | +$2.02M |
|
1072
lululemon athletica
LULU
$13.9B
| $13M | 0.02% |
209,249
-398,279
| -66% | -$24M |
|
|
RDC
1073
DELISTED
Rowan Companies Plc
RDC
| $13M | 0.02% |
1,012,686
-2,471,563
| -71% | -$26.5M |
|
|
MLNX
1074
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $13M | 0.02% |
275,623
-63,106
| -19% | -$2.86M |
|
1075
Euronet Worldwide
EEFT
$2.63B
| $13M | 0.02% |
136,990
+114,689
| +514% | +$10.9M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.